Serum indoleamine 2,3-dioxygenase and kynurenine aminotransferase enzyme activity in patients with ischemic stroke

Journal of Clinical Neuroscience

Volumn 21, Issue 3, 2014, Pages 482-486

  Mo, Ximing ^a   Pi, Langan ^b   Yang, Jingjing ^a   Xiang, Zhongyuan ^a   Tang, Aiguo ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Chenzhou No1 People's Hospital   (China)

Author keywords

High sensitivity C reactive protein; Indoleamine 2,3 dioxygenase; Ischemic stroke; Kynurenine acid; Kynurenine aminotransferase

Indexed keywords

HIGH-SENSITIVITY C-REACTIVE PROTEIN; INDOLEAMINE 2,3-DIOXYGENASE; ISCHEMIC STROKE; KYNURENINE ACID; KYNURENINE AMINOTRANSFERASE;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INFLAMMATION; MALE; MIDDLE AGED; STROKE; TRANSAMINASES;

EID: 84895157349     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2013.08.020     Document Type: Article

References (25)

1. P.J. Camarata, R.C. Heros, and R.E. Latchaw Brain attack: the rationale for treating stroke as a medical emergency Neurosurgery 34 1994 144 157
2. C.D. Wolfe The impact of stroke Br Med Bull 56 2000 275 286
3. K. Strong, C. Mathers, and R. Bonita Preventing stroke: saving lives around the world Lancet Neurol 6 2007 182 187
4. N. Kostulas, S.H. Pelidou, and P. Kivisakk et al. Increased IL-1beta, IL-8, and IL-17 mRNA expression in blood mononuclear cells observed in a prospective ischemic stroke study Stroke 30 1999 2174 2179
5. E. Tarkowski, L. Rosengren, and C. Blomstrand et al. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke Stroke 26 1995 1393 1398
6. C. Liebau, A.W. Baltzer, and S. Schmidt et al. Interleukin-12 and interleukin-18 induce indoleamine 2,3-dioxygenase (IDO) activity in human osteosarcoma cell lines independently from interferon-gamma Anticancer Res 22 2002 931 936
7. B. Widner, A. Laich, and B. Sperner-Unterweger et al. Neopterin production, tryptophan degradation, and mental depression-what is the link? Brain Behav Immun 16 2002 590 595
8. L. Vécsei, L. Szalárdy, and F. Fülöp et al. Kynurenines in the CNS: 324 recent advances and new questions Nat Rev Drug Discovery 12 2013 64 82
9. Z.Y. Xiang, A.G. Tang, and Y.P. Ren et al. Simultaneous determination of serum tryptophan metabolites in patients with systemic lupus erythematous by high performance liquid chromatography with fluorescence detection Clin Chem Lab Med 48 2010 513 517
10. L.G. Pi, A.G. Tang, and X.M. Mo et al. More rapid and sensitive method for simultaneous determination of tryptophan and kynurenic acid by HPLC Clin Biochem 42 2009 420 425
11. R. Brouns, and P.P. De Deyn The complexity of neurobiological processes in acute ischemic stroke Clin Neurol Neurosurg 111 2009 483 495
12. M. Pertovaara, A. Raitala, and T. Lehtimaki et al. Indoleamine 2,3-dioxygenase activity in nonagenarians is markedly increased and predicts mortality Mech Ageing Dev 127 2006 497 499
13. W. Swardfager, N. Herrmann, and Y. Dowlati et al. Indoleamine 2,3-dioxygenase activation and depressive symptoms in patients with coronary artery disease Psychoneuroendocrinology 34 2009 1560 1566
14. S.B. Park, J.T. Coull, and R.H. McShane et al. Tryptophan depletion in normal volunteers produces selective impairments in learning and memory Neuropharmacology 33 1994 575 588
15. W.J. Riedel, T. Klaassen, and N.E. Deutz et al. Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation Psychopharmacology 141 1999 362 369
16. H. Baran, K. Jellinger, and L. Deecke Kynurenine metabolism in Alzheimer's disease J Neural Transm 106 1999 165 181
17. M.C. Potter, G.I. Elmer, and R. Bergeron et al. Reduction of endogenous kynurenic acid formation enhances extracellular glutamate, hippocampal plasticity, and cognitive behavior Neuropsychopharmacology 35 2010 1734 1742
18. B. Widner, F. Leblhuber, and J. Walli et al. Tryptophan degradation and immune activation in Alzheimer's disease J Neural Transm 107 2000 343 353
19. L.G. Darlington, G.M. Mackay, and C.M. Forrest et al. Altered kynurenine metabolism correlates with infarct volume in stroke Eur J Neurosci 26 2007 2211 2221
20. T.W. Stone, and L.G. Darlington Endogenous kynurenines as targets for drug discovery and development Nat Rev Drug Discov 1 2002 609 620
21. L. Amori, P. Guidetti, and R. Pellicciari et al. On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo J Neurochem 109 2009 316 325
22. G. Gigler, G. Szénási, and A. Simó et al. Neuroprotective effect of l-kynurenine sulfate administered before focal cerebral ischemia in mice and global cerebral ischemia in gerbils Eur J Pharmacol 564 2007 116 122
23. F. Moroni, R. Carpenedo, and A. Cozzi et al. Studies on the neuroprotective action of kynurenine mono-oxygenase inhibitors in post-ischemic brain damage Adv Exp Med Biol 527 2003 127 136
24. P.M. Ridker C-reactive protein: a sample test to help predict risk of heart attack and stroke Circulation 108 2003 e81 e85
25. G.M. Mackay, C.M. Forrest, and N. Stoy et al. Tryptophan metabolism and oxidative stress in patients with chronic brain injury Eur J Neurol 13 2006 30 42